Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current programs include:
More disciplines coming soon……
Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions
You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
NEW Respiratory. In terms of difficult asthma, we’re in very exciting times! We now have the opportunity to substantially minimise exposure of patients to oral corticosteroids to try and minimise the burden of illness. In this interview we discuss identifying patients that would benefit from a reduction in oral corticosteroids, tips on down-titrating oral corticosteroids and starting patients on biologic agents.
Prof. Peter Wark, Senior Staff Specialist, Respiratory & Sleep Medicine, John Hunter Hospital, Newcastle & Conjoint Professor, University of NewcastleNEW Respiratory. There are now three biologic agents for severe refractory asthma available in Australia. These agents when chosen appropriately can improve asthma control and decrease the risk of exacerbations. We need to ensure that these therapies are given to the right sort of patient, so what factors do we need to consider?
Prof Paul Thomas, Respiratory & Sleep Medicine Physician, SydneyNEW Neurology. Making a diagnosis of epilepsy can be difficult, particularly establishing the difference between focal and generalised seizures, and this differential is critical. In this interview we discuss this, as well as how to ensure the patient gets the right treatment, early on.
A/Prof. Wendyl D’Souza, Epileptologist, St Vincent’s Hospital, MelbourneNEW Neurology. One of the most difficult areas of practice for neurologists are the rules and regulations around driving with epilepsy. There’s a lot of confusion and immense interest in this topic, so in this interview we discuss the social consequences and the practical issues.
Prof. Ernest Somerville, Neurologist, Sydney, Chair of Australian & New Zealand Association of Neurologists’ Driving CommitteeNEW Ophthalmology. Led by Diabetes Australia and Vision 2020 Australia, the NEW KeepSight initiative will engage with 1.27 million people with diabetes who are registered on the National Diabetes Services Scheme (NDSS). How will the KeepSight program ultimately change the management of diabetic retinopathy in Australia, and what do you as ophthalmologists need to do?
Dr Peter van Wijngaarden, Interim Managing Director, Centre for Eye Research Australia & Consultant Ophthalmologist, The Royal Victorian Eye and Ear HospitalNEW Ophthalmology. New screening programs in Australia will help improve the detection rates of diabetic retinopathy, leading to earlier detection and treatment. Early detection and treatment can prevent the majority of vision loss and blindness in patients with diabetes, so how can we shift the care from what is now, very expensive hospital-based care, where ophthalmologists need laser treatment and intensive anti-VEFG injections, towards more primary and secondary care?
Prof. Tien Y Wong, MD, PhD, Professor & Medical Director, Singapore National Eye Center, Chairman, Singapore Eye Research Institute & Vice-Dean, Duke-NUS Medical School, National University of SingaporeNEW Psychiatry. People with psychotic disorders have high levels of co-morbidity and sadly their life expectancy is reduced by 10-25 years. Thinking long-term from the beginning is key, so in the first part of this interview we discuss the efficacy across all current treatments and the side effect profile, including short-term effects such as sedation and long-term concerns with weight and particularly metabolic functioning.
Dr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New YorkNEW Psychiatry. We now have more options within the atypical antipsychotic range, so in the second part of this interview with Cristoph Correll, we discuss the evidence for effective medications that also have relatively little cardiometabolic burden.
Dr Christoph Correll, Professor of Psychiatry, the Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, New YorkNEW Psychiatry. In this interview we discuss the link between depression and altered circadian rhythm, plus the role of melatonergic receptors and 5HT-2C receptors in the regulation of circadian rhythm and the treatment of depression.
Dr Stephen Stahl, University of California, San DiegoNEW Psychiatry. Identifying symptoms of depression and patient willingness to start treatment are key challenges to effective treatment. Patient preference, as well as the features of the episode are important considerations, so we talk to both a patient and David Horgan about patient-centred care for depression.
Associate Professor David Horgan, Psychiatrist, Victoria
Tap the share icon 
and select 'Add to Home Screen' to add the site to your home screen for quick access!